LetterLetter
Gamma Delta T Cell Subset V Gamma 2+ Expansion Associated with Longterm Infliximab Treatment in a Patient with Ankylosing Spondylitis
ERIC GRACEY, ZOYA QAIYUM, JOHN KURUVILLA and ROBERT D. INMAN
The Journal of Rheumatology November 2016, 43 (11) 2079-2082; DOI: https://doi.org/10.3899/jrheum.160425
ERIC GRACEY
Department of Immunology, University of Toronto, and Toronto Western Hospital, University Health Network;
PhDZOYA QAIYUM
Department of Immunology, University of Toronto, and Toronto Western Hospital, University Health Network;
BScJOHN KURUVILLA
Princess Margaret Hospital, University Health Network;
MDROBERT D. INMAN
Department of Immunology, University of Toronto, and Toronto Western Hospital, University Health Network, Toronto, Ontario,
Canada.
MDREFERENCES
- 1.↵
- 2.↵
- 3.↵
- 4.↵
- 5.↵
- Michel ML,
- Pang DJ,
- Haque SF,
- Potocnik AJ,
- Pennington DJ,
- Hayday AC
- 6.↵
- 7.↵
- 8.↵
- 9.↵
- 10.↵
- 11.↵
- Py B,
- Slomianny C,
- Auberger P,
- Petit PX,
- Benichou S
- 12.↵
- Prasad KV,
- Ao Z,
- Yoon Y,
- Wu MX,
- Rizk M,
- Jacquot S,
- et al.
In this issue
The Journal of Rheumatology
Vol. 43, Issue 11
1 Nov 2016
Gamma Delta T Cell Subset V Gamma 2+ Expansion Associated with Longterm Infliximab Treatment in a Patient with Ankylosing Spondylitis
ERIC GRACEY, ZOYA QAIYUM, JOHN KURUVILLA, ROBERT D. INMAN
The Journal of Rheumatology Nov 2016, 43 (11) 2079-2082; DOI: 10.3899/jrheum.160425